U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 1,583 records

Showing results for "liver".
Users also searched for: hepatitis c

  1. EPC-Pilot-Project-A-Dual-Approach-To-Facilitate-Health-Systems-Uptake-Of-Evidence-Synthesis-Reports-Anxiety-In-Children (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
    October 01, 2018 - interventions with important adverse effects; such as nefazodone (which can be associated with sudden onset liver

  2. Evidence-based Practice Center Systematic Review Protocol: Malnutrition in Hospitalized Adults (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/malnutrition-hospitalized-adults-protocol.pdf
    October 19, 2020 - subsequent malabsorption, including ulcerative colitis and Crohn’s disease • Patients with chronic liver

  3. Errors in Managing an Open Wound of the Elbow Leading to Multiple Complications and Operations | PSNet

    psnet.ahrq.gov/web-mm/errors-managing-open-wound-elbow-leading-multiple-complications-and-operations
    September 27, 2023 - bodies associated with traumatic lacerations The Case A man with a history of hypertension and fatty liver

  4. In Conversation with...Barbara Pelletreau and John Riggi about Cybersecurity | PSNet

    psnet.ahrq.gov/perspective/conversation-withbarbara-pelletreau-and-john-riggi-about-cybersecurity
    March 27, 2024 - Multitasking Mishap December 1, 2011 WebM&M Cases Liver

  5. AHRQ Evidence-Based Practice Center (EPC) Program Research Gaps Summary: Pain Management (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
    January 01, 2023 - NSAIDs have increased risk of serious gastrointestinal, liver dysfunction, and cardiovascular adverse

  6. Improving Safety and Quality with Outpatient Order Entry (pdf file)

    digital.ahrq.gov/sites/default/files/docs/publication/r01hs015226-gandhi-final-report-2008.pdf
    January 01, 2008 - Medications requiring monitoring by type of laboratory test Renal Function Thyroid Function Liver

  7. S96 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
    October 01, 2007 - ORIGINAL ARTICLE Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES) Michael A. Jhung, MD, MPH,* Daniel S. Budnitz, MD, MPH,* Aaron B. Mendelsohn, PhD,*† Kelly N. Weidenbach, MPH,* Theresa D. Nelson, MS,‡ and Daniel A. Polloc…

  8. Archived: Evidence Summary: Screening for Dyslipidemia in Younger Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-dyslipidemia/statin-use-in-adults-preventive-medication-november-2016
    November 13, 2016 - with drug treatment (e.g., myopathy, rhabdomyolysis, myalgia, cognitive loss, diabetes, elevations in liver

  9. Final Progress Report: Improving Safety and Quality with Outpatient Order Entry (pdf file)

    www.ahrq.gov/sites/default/files/2024-02/gandhi-report.pdf
    January 01, 2024 - Medications requiring monitoring by type of laboratory test Renal Function Thyroid Function Liver Function

  10. Operational Redesign Through Workflow Analysis (pdf file)

    digital.ahrq.gov/sites/default/files/docs/workflowtoolkit/IFQHC_operational_redesign_patient_flow_worksheet.pdf
    January 01, 2007 - HgbA C for diabetics, EF for CHF patients, amylase/lipase for liver patients, BUN and creatinines for

  11. Evidence Summary: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/lipid-disorders-in-children-screening
    July 18, 2023 - Limited longer-term evidence shows few withdrawals due to adverse events, slightly higher rates of liver … Clinical importance of transient elevations in these laboratory values is unknown Low for reversible liver

  12. Final progress Report: Anticholinergics and Cognitive Decline in the Elderly with Depression (pdf file)

    www.ahrq.gov/sites/default/files/2024-01/aparasu-report.pdf
    January 01, 2024 - heart failure, vascular diseases, dementia, cerebrovascular events, rheumatological diseases, mild liver … pulmonary disorders, renal diseases, ulcer, hemiplegia, diabetes, cancer, metastasis, and moderate/chronic liver

  13. Disposition of Comments for Pulmonary Arterial Hypertension: Screening, Management, and Treatment (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
    April 25, 2013 - Hg if there is evidence for increased stroke volume which occurs commonly in patients with anxiety, liver … KQ1L For echocardiography, screening populations were SSc, liver transplant and Sickle cell disease. … For liver transplants, diagnostic criteria use PVR>120 for several studies which may be too low. … KQ2: These studies rely heavily on SSc and liver disease. Few studies of IPAH.

  14. Statistical Brief #86: Hospital-Based Ambulatory Surgery, 2007 (pdf file)

    hcup-us.ahrq.gov/reports/statbriefs/sb86.pdf
    February 01, 2010 - 82 Endoscopic cannulation of pancreas (ERCP) 42.1 26.9 21.7 13.9 61.0 $6,115 $32,782 83 Biopsy of liver

  15. Availability Of Kid Data Elements 2009 (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/Availability_of_KID_Data_Elements_2009.pdf
    January 01, 2009 - comorbidity measure: Hypothyroidism -- -- Yes Yes Yes CM_HYPOTHY CM_LIVER Severity AHRQ comorbidity measure: Liver

  16. MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - Pulmonary circulation disorders, Paralysis, Other neurologic disorders, Chronic pulmonary disease, Liver

  17. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)

    www.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
    January 01, 2024 - For example, post-marketing surveillance data have suggested that rituximab can result in fulminant liver

  18. AHRQ Safety Program for MRSA Prevention: Targeting SSI

    www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa-2/004-ss-antimicrobial-prophylaxis-part-2.pptx
    April 01, 2025 - PMID: 29751965. 30 | 31 Contraindications to cefazolin DRESS, AGEP, SJS/TEN25 Drug-induced liver

  19. Spleen Diseases | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/health-topics/spleen-diseases

  20. Organ Donation | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/health-topics/organ-donation
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

hcup-us.ahrq.gov (496)

effectivehealthcare.ahrq.gov (343)

psnet.ahrq.gov (259)

www.uspreventiveservicestaskforce.org (230)

www.ahrq.gov (171)

digital.ahrq.gov (57)

cds.ahrq.gov (15)

integrationacademy.ahrq.gov (4)

meps.ahrq.gov (4)

cdsic.ahrq.gov (1)

datatools.ahrq.gov (1)

pso.ahrq.gov (1)

qualityindicators.ahrq.gov (1)